Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

VivioMD vs WeightCare

VivioMD
Graded #401

Lower grade

vs+1.3000000000000043
WeightCare
Graded #368

Higher grade

The verdict

WeightCare takes it — 58.6/100 to 57.3/100, but only just.

WeightCare grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. WeightCare offers compounded semaglutide ($249–$399/mo) and tirzepatide ($349/mo) dispensed by FDA-registered, PCAB-accredited pharmacies. VivioMD is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVivioMD +10
45
35
Dose & formulationWeightCare +22
40
62
Clinical oversightWeightCare +7
80
87
Labs & monitoringWeightCare +1
53
54
FulfillmentVivioMD +9
81
72
Contract termsVivioMD +14
55
41
VivioMD · left barWeightCare · right bar

The numbers

MetricVivioMDWeightCare
WeighScore57.3/10058.6/100
GradeCC
Scorecard rank#401#368
SemaglutideNot disclosed$399/mo
TirzepatideNot disclosed$499/mo (15 mg dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
VivioMD

Graded #401 · C

Strengths

  • Telehealth convenience
  • Physician-supervised program

Where it loses points

  • GLP-1 medications not currently offered
WeightCare

Graded #368 · C

Strengths

  • PCAB-accredited pharmacy partners — strongest pharmacy quality signal
  • Quality testing: potency and sterility per USP 797 standards
  • 85,000+ members since 2022 — established patient base
  • Multiple program tiers for semaglutide
  • Health coaching, dietitians, fitness trainers included

Where it loses points

  • No LegitScript certification on the site itself
  • State availability not explicitly listed
  • Compounded only — no brand-name options
  • Semaglutide runs $215-$399/mo and tirzepatide $275-$499/mo depending on plan length and dose

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard